SCHEMBL5823667

SCHEMBL5823667

Cc1cnc(Cl)nc1N(CC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.43
STK17A Q9UEE5 1/20 0.43
AAK1 Q2M2I8 5/20 0.37
NUDT1 P36639 1/20 0.36
ATR Q13535 1/20 0.34
MAPKAPK2 P49137 3/20 0.33
SYK P43405 1/20 0.33
TRPA1 O75762 1/20 0.32
AKT1 P31749 2/20 0.32
PDK1 Q15118 2/20 0.32
CKS1B P61024 1/20 0.31
SKP1 P63208 1/20 0.31
SKP2 Q13309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306339 0.89 STK17B (0.49) STK17BSTK17AAAK1ATRMAPKAPK2
SCHEMBL3176616 0.87 STK17B (0.42) STK17BSTK17AAAK1ATRMAPKAPK2
SCHEMBL8244837 0.87 STK17B (0.42) STK17BSTK17AAAK1ATRMAPKAPK2
SCHEMBL5792631 0.86 STK17B (0.42) STK17BSTK17AAAK1TRPA1
SCHEMBL5791907 0.83 CTSS (0.34) AAK1NUDT1MAPKAPK2SYKAKT1
SCHEMBL8125809 0.77 ATR (0.42) STK17BSTK17AAAK1ATRMAPKAPK2
SCHEMBL8243223 0.76 STK17B (0.41) STK17BSTK17AAAK1ATRMAPKAPK2
SCHEMBL5304940 0.76 STK17B (0.41) STK17BSTK17AAAK1ATRMAPKAPK2
SCHEMBL5306326 0.75 STK17B (0.47) STK17BSTK17AAAK1ATRTRPA1
SCHEMBL5303425 0.75 STK17B (0.38) STK17BSTK17AAAK1ATRMAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006027211-A1 2,4-SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2006-03-16 WO disclosed